Typical attendees include science-based professionals: biologists, molecular biologists, chemists, preclinical development scientists, informaticians, patent attorneys, project managers and general managers.

A two day course.

The attendee should gain a good, basic working knowledge of today’s drug discovery science, technology and process.

The course is a ‘one-stop-shop’ outlining the major scientific tools of drug discovery, namely Drug Discovery-specific: Biology, ADMET/PK/PD, Medicinal Chemistry and Informatics and how each is phased and integrated over time to generate a drug suitable for clinical trials.

The focus is on small molecule drugs with comparisons made with biologics. Based on real-world experience and practical realities, attendees travel step-by-step along a typical drug discovery path, namely: Initiating Idea and Project Initiation -> Drug Target Protein Selection -> Lead Identification -> Clinical Candidate Nomination. 

Essential related topics include: drug discovery technology platforms, infrastructure requirements, drug structural-functional quality attributes, typical organisational structures and Project management tools, including Target Product Profile (TPP) use.

You can see the full course contents here.

Gold Members: £392 + VAT
Silver Members: £476 + VAT
Non-members: £560 + VAT